0001144204-18-054173.txt : 20181017 0001144204-18-054173.hdr.sgml : 20181017 20181017141945 ACCESSION NUMBER: 0001144204-18-054173 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181017 FILED AS OF DATE: 20181017 DATE AS OF CHANGE: 20181017 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bitzer John III CENTRAL INDEX KEY: 0001624610 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36745 FILM NUMBER: 181126154 MAIL ADDRESS: STREET 1: C/O APPLIED DNA SCIENCES, INC. STREET 2: 50 HEALTH SCIENCES DRIVE CITY: STONY BROOK STATE: NY ZIP: 11790 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: APPLIED DNA SCIENCES INC CENTRAL INDEX KEY: 0000744452 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISCELLANEOUS BUSINESS SERVICES [7380] IRS NUMBER: 592262718 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 50 HEALTH SCIENCES DRIVE CITY: STONY BROOK STATE: NY ZIP: 11790 BUSINESS PHONE: 631-240-8800 MAIL ADDRESS: STREET 1: 50 HEALTH SCIENCES DRIVE CITY: STONY BROOK STATE: NY ZIP: 11790 FORMER COMPANY: FORMER CONFORMED NAME: PROHEALTH MEDICAL TECHNOLOGIES INC DATE OF NAME CHANGE: 20010504 FORMER COMPANY: FORMER CONFORMED NAME: DCC ACQUISITION CORP DATE OF NAME CHANGE: 19990211 FORMER COMPANY: FORMER CONFORMED NAME: DATALINK CAPITAL CORP/TX/ DATE OF NAME CHANGE: 19980306 4 1 tv504853_4.xml FORM 4 X0306 4 2018-10-17 0 0000744452 APPLIED DNA SCIENCES INC APDN 0001624610 Bitzer John III 50 HEALTH SCIENCES DRIVE STONY BROOK NY 11790 1 0 0 0 Stock Option (right to buy) 5.82 2018-10-17 4 D 0 12778 0 D 2018-10-17 Common Stock 12778 0 D Stock Option (right to buy) 5.82 2018-10-17 4 A 0 12778 0 A 2023-10-17 Common Stock 12778 12778 D The two reported transactions involve an amendment of an outstanding option to extend the expiration date of such option from October 17, 2018 to October 17, 2023, resulting in the deemed cancelation of the "old" option and the grant of a replacement option. The option was originally granted on October 17, 2013 and provided for immediate vesting upon date of grant. /s/ Beth Jantzen, Attorney-in-Fact 2018-10-17